Personalis, Inc. - Common Stock (NQ:PSNL)

16.40 +0.12 (+0.74%)

Delayed Quote Updated: 1:39 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing

October 16, 2025

From Personalis, Inc.

Via Business Wire

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 15, 2025

From Personalis, Inc.

Via Business Wire

CATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal Test

September 10, 2025

From Personalis, Inc.

Via Business Wire

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

September 03, 2025

From Personalis, Inc.

Via Business Wire

Personalis to Participate in Upcoming Investor Conferences

August 27, 2025

From Personalis, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 06, 2025

Via Benzinga

The market is filled with gapping stocks in Wednesday's session. ↗

August 06, 2025

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Discover the top movers in Wednesday's pre-market session. ↗

August 06, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 06, 2025

Via Benzinga

Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket ↗

August 06, 2025

Via Benzinga

Personalis (PSNL) Q2 Revenue Falls 24% ↗

August 06, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 05, 2025

Via Benzinga

Top movers in Tuesday's after hours session ↗

August 05, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Personalis Reports Second Quarter 2025 Financial Results

August 05, 2025

From Personalis, Inc.

Via Business Wire

Personalis to Announce Second Quarter 2025 Financial Results

July 22, 2025

From Personalis, Inc.

Via Business Wire

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 18, 2025

From Personalis, Inc.

Via Business Wire

Cramer Says Tesla Dominates While Ouster Is 'Too Speculative' ↗

July 10, 2025

Jim Cramer advises against investing in Tempus AI due to its ongoing losses and suggests Pan American as a profitable alternative. Insmed is also considered speculative while the only viable option for...

Via Benzinga

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 09, 2025

Via Benzinga

What's going on in today's after hours session ↗

July 09, 2025

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

July 09, 2025

From Personalis, Inc.

Via Business Wire

Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO

June 03, 2025

From Personalis, Inc.

Via Business Wire

New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse

June 02, 2025

From Personalis, Inc.

Via Business Wire

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection

May 22, 2025

From Personalis, Inc.

Via Business Wire

Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference

May 14, 2025

From Personalis, Inc.

Via Business Wire

Analyst Expectations For Personalis's Future ↗

May 07, 2025

Via Benzinga

Personalis Reports First Quarter 2025 Financial Results

May 06, 2025

From Personalis, Inc.

Via Business Wire

Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study

April 28, 2025

From Personalis, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.